GUT:儿童肿瘤幸存者后续消化系统原发性肿瘤风险

2020-11-03 MedSci原创 MedSci原创

儿童肿瘤幸存者的后续消化系统肿瘤风险增加,特别是Wilms瘤和霍奇金淋巴瘤幸存者

儿童肿瘤幸存者后续的原发性肿瘤(SPNS)风险较高,但在40岁以上发展为特定消化系统SPNS的风险仍然不确定。近日研究人员开展大规模世界可用队列研究,以确定儿童肿瘤幸存人群的后续特定消化系统SPNS风险。
 
PanCareSurFup队列包含12个欧洲国家总计69460名儿童肿瘤幸存患者,研究人员对队列人群的后续消化系统原发性肿瘤标准化发病率 (SIRS)、绝对额外风险和累积发病率进行考察。
 
413名幸存者中发生了427起后续SPN事件,其中结肠癌214例,肝癌62例,胃癌48例,胰腺癌44例,其他肿瘤59例。Wilms瘤(Wt,SIR=12.1)和霍奇金淋巴瘤(HL,SIR=7.31)幸存者的风险最大。随着WT幸存者年龄的增加,累积发病率增加最快,55岁时达到7.4%,到60岁达到9.6%。对于肠道SPNs,WT及HL幸存者的风险仍最高,超过一般人群7倍。55岁时,WT及HL幸存者的肠道SPN风险均为2.3% 。
 
儿童肿瘤幸存者的后续消化系统肿瘤风险增加,特别是Wilms瘤和霍奇金淋巴瘤幸存者。
 
原始出处:
 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2022-06-01 ms7000000250189217

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2021-04-30 MedSciZeng

    #Gut#点击进入话题查看更多相关文章 或评论时插入话题加入讨论

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2021-04-12 生物医学Sci

    需要发2区生物,医学Sci的私聊我

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2021-01-20 lifefamily

    #肿瘤#这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2021-01-17 12558bb4m93暂无昵称

    学习到了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
    2020-11-09 14773283m05暂无昵称

    学习的

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1223954, encodeId=2ac3122395491, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ac5431000, createdName=ms7000000250189217, createdTime=Wed Jun 01 23:57:58 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026053, encodeId=9d92202605375, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sat Dec 12 13:53:43 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961915, encodeId=391696191521, content=<a href='/topic/show?id=49e383289e' target=_blank style='color:#2F92EE;'>#Gut#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8328, encryptionId=49e383289e, topicName=Gut)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:30:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956154, encodeId=6db09561543d, content=需要发2区生物,医学Sci的私聊我, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bbb5479610, createdName=生物医学Sci, createdTime=Mon Apr 12 14:08:45 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846937, encodeId=d2e6184693e7b, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Jan 25 13:53:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918531, encodeId=56fd918531f4, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>这个研究十分有价值,但是难度极大。对于肿瘤幸存者而言,二次肿瘤的风险同样值得评估, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Wed Jan 20 21:11:06 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917372, encodeId=3a7291e37280, content=学习到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/732da2c721de40ecb9f593b492349552/2447c39af1654f828c1a9a0e3bf923e1.jpg, createdBy=74192558481, createdName=12558bb4m93暂无昵称, createdTime=Sun Jan 17 10:51:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898005, encodeId=1cb989800522, content=学习的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/8cdf699bf422425fb5bd7afd56637bbf/9e1f3804bae241f9b81379a2ae783698.jpg, createdBy=9de15217886, createdName=14773283m05暂无昵称, createdTime=Mon Nov 09 16:41:32 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345171, encodeId=07cc13451e141, content=<a href='/topic/show?id=f1e0284214e' target=_blank style='color:#2F92EE;'>#儿童肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28421, encryptionId=f1e0284214e, topicName=儿童肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462680, encodeId=bf73146268003, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Thu Nov 05 00:53:43 CST 2020, time=2020-11-05, status=1, ipAttribution=)]

相关资讯

Sci Transl Med:轮状病毒疫苗助力儿童肿瘤告别免疫抑制

近日,法国的一个研究团队将轮状病毒疫苗应用于癌症治疗,不仅发挥了其溶瘤作用,还可消除“冷肿瘤”存在的免疫抑制环境,成功克服了ICB治疗的耐药性!

Lancet:印度、中国、巴西和墨西哥5-14岁儿童死亡负担研究

研究发现,在印度、中国、巴西和墨西哥,大多数5-14岁儿童的死亡都是由可预防或可治疗的疾病造成的,进行有目的的干预控制非传染性疾病和伤害是减少低龄儿童及青少年死亡的重要方法

JCO:小儿脑肿瘤患者耳毒性的认知意义

已有的研究显示,感觉神经性听力损失(SNHL)与胚胎脑肿瘤儿童的智力和学业下降有关。 最近的一项研究通过检查可能导致治疗相关耳毒性儿童阅读困难的核心神经认知过程,扩展了现有研究。

ASCO 2020丨儿童肿瘤精准治疗获得新助力!优先级算法可行性佳

2020年美国临床肿瘤学会(ASCO)年会已经拉开帷幕,这场学术盛宴可谓精彩纷呈,赢得了全世界肿瘤医生的瞩目。

BMJ:儿童肿瘤幸存者主要心血管事件风险研究

研究发现,儿童肿瘤幸存者中,心脏辐射暴露减少降低了冠状动脉疾病风险

2019 儿童肿瘤和造血干细胞移植患者抗菌预防管理指南

菌血症和其他侵袭性细菌感染在接受强化化疗以及造血干细胞移植的儿童患者中非常常见,系统性抗菌预防可减少这些感染风险。本文的主要目的是针对儿童肿瘤和造血干细胞移植患者抗菌预防管理提供指导意见。